Stock listing
BOATS:CTY City Therapeutics, Inc. Stock
US listing (BOATS) of City Therapeutics, Inc. · home listing NASDAQ:CTY
Follow City Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:CTY
$16.41 USD -2.68 (-14.0%)
Close on Nov 4, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CTY
- Day range
- $16.22 – $20.07 USDNov 4, 2026
- Volume
- 359,719 sharesNov 4, 2026
- Market cap
- $826.0M USDAt the close on Nov 4, 2026 · price × 50.33M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CTY · Home | $16.41 USD | -2.68 (-14.0%) | 359,719 | $19.37 | $20.07 | $16.22 | $19.09 | Close on Nov 4, 2026 |
Daily closes
Last 3 months, Oct 16, 2026 – Nov 4, 2026 · NASDAQ:CTY · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $16.41 | -2.68 | -14.0% | $19.37 | $20.07 | $16.22 | 359,719 | |
| $19.09 | -1.79 | -8.6% | $21.12 | $21.12 | $18.77 | 275,529 | |
| $20.88 | +0.17 | +0.8% | $21.08 | $22.65 | $20.39 | 224,372 | |
| $20.71 | -1.43 | -6.5% | $22.08 | $22.26 | $20.37 | 116,775 | |
| $22.14 | +0.49 | +2.3% | $21.63 | $22.35 | $21.54 | 130,916 | |
| $21.65 | +0.79 | +3.8% | $20.89 | $21.96 | $20.50 | 335,293 | |
| $20.86 | +0.07 | +0.3% | $20.79 | $21.59 | $20.70 | 214,807 | |
| $20.79 | +0.02 | +0.1% | $20.62 | $21.31 | $20.30 | 136,056 | |
| $20.77 | 0.00 | 0.0% | $20.62 | $21.14 | $20.03 | 343,835 | |
| $20.77 | +0.34 | +1.7% | $20.41 | $20.88 | $19.75 | 127,600 | |
| $20.43 | -0.40 | -1.9% | $20.78 | $21.69 | $19.97 | 283,100 | |
| $20.83 | -0.63 | -2.9% | $21.44 | $21.50 | $20.00 | 632,800 | |
| $21.46 | -0.94 | -4.2% | $21.94 | $22.00 | $21.03 | 302,400 | |
| $22.40 | — | — | $23.00 | $23.88 | $20.50 | 1,406,100 |
- Ticker
- BOATS:CTY
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news
Phase 1 Data for CITY-FXI, an RNAi Therapeutic Candidate for Thromboembolic Diseases, Selected for Oral Presentation at the 68th ASH Annual Meeting
Nov 4, 2026
Closed $16.41 (-14.0%) on Nov 4, 2026
City Therapeutics to Present at Upcoming November Investor Conferences
Nov 3, 2026
Closed $19.09 (-8.6%) on Nov 3, 2026
Financings
Public offering of common stock
Oct 19, 2026
Closed: US$230M raised · US$18 a share · Goldman Sachs & Co. LLC +3
Dealers: Goldman Sachs & Co. LLC (co-lead), Jefferies (co-lead), Stifel (co-lead), Oppenheimer & Co. (co-lead)
City Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 3 in the last 12 months · 3 in all · newest Nov 4, 2026 · oldest 2026
Where City Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CTY · Home listing | NASDAQ | United States | USD |
| BOATS:CTY · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about City Therapeutics, Inc.